Stock Price
61.36
Daily Change
-1.20 -1.92%
Monthly
-12.47%
Yearly
-37.91%
Q2 Forecast
60.13

Merit Medical Systems reported $41M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
3M USD 653M 76M Mar/2026
Abbott USD 1.08B 699M Mar/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Anika Therapeutics USD 292K 2.62M Dec/2025
AtriCure USD 108K 1.65M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 41M 2.99M Mar/2026
Olympus JPY 24.82B 10.65B Mar/2026
Pfizer USD 2.69B 4.34B Mar/2026
STAAR Surgical USD 5.21M 23.52M Mar/2026
Stryker USD 745M 104M Mar/2026
Surmodics USD -5.32M 6.22M Jun/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Terumo JPY 32.65B 2.4B Dec/2025
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026